Effect of PKC inhibition on cell migration and invasion of oral squamous cell carcinoma

doi:10.19439/j.sjos.2017.02.009

Abstract

Abstract: PURPOSES: By using HN4 cells, the correlation among protein kinase C(PKC), P120-catenin(P120ctn) and E-cadherin (E-cad) was investigated, and the role of them in migration and invasion of oral squamous-cell cancer(OSCC) was evaluated. METHODS: Plasmid pGFP-V-RS-P120ctn shRNA was used to transfect HN4 cells to significantly reduce the expression of P120ctn and PKC inhibitor staurosporine (STS) was added. mRNA and protein expression of PKC, P120ctn and E-cad were tested and Transwell cell invasion and cell migration assay was used to test the invasion and migration capacity before and after PKC inhibition. Statistical analysis was performed using SPSS 18.0 software package. RESULTS: When PKC was inhibited by STS, the expression of P120ctn and E-cad in OSCC cells were increased and the migration and invasion capacity of tumor cells decreased significantly (P<0.05). CONCLUSIONS: PKC may be involved in the process of HN4 migration and invasion by regulating cell adhesion through the effect of P120ctn and E-cad.

Key words: P120-catenin, Protein kinase C, Oral cavity, Squamous-cell cancer

CLC Number:

R739.8

CHEN Zhong, XU Yong, JI Qing. Effect of PKC inhibition on cell migration and invasion of oral squamous cell carcinoma[J]. Shanghai Journal of Stomatology, 2017, 26(2): 171-174.

References

[1] Zhang LL, Cao FF, Wang Y, et al. The protein kinase C (PKC) inhibitors combined with chemotherapy in the treatment of advanced non-small cell lung cancer: meta-analysis of randomized controlled trials[J]. Clin Transl Oncol, 2015, 17(5): 371-377.
[2] Butler AM, Scotti Buzhardt ML, Erdogan E, et al. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion [J]. Oncotarget, 2015, 6(17): 15297-15310.
[3] Jatoi A, Radecki Breitkopf C, Foster NR, et al. A mixed-methods feasibility trial of Protein Kinase C Iota inhibition with Auranofin in asymptomatic ovarian cancer patients[J]. Oncology, 2015, 88(4): 208-213.
[4] 陈钟, 董孟华, 邓锋. PKC、P120ctn和E- cad在口腔鳞癌中的表达 [J]. 实用口腔医学杂志, 2014, 30(1): 61-65.
[5] Wang H, Patel V, Miyazaki H, et al. Role for EPS8 in squamous carcinogenesis [J]. Carcinogenesis, 2009, 30(1): 165-174.
[6] Xiong H, Hong J, Du W, et al. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition [J]. J Biol Chem, 2012, 287(8): 5819-5832.
[7] Zaid KW. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma [J]. Asian Pac J Cancer Prev, 2014, 15(20): 8847-8853.
[8] Pannone G, Santoro A, Feola A, et al. The Role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage[J]. Current Cancer Drug Targets, 2014, 14(2): 115-127.
[9] Nanes BA, Chiasson-MacKenzie C, Lowery AM, et al. P120-catenin binding masks an endocytic signal conserved in classical cadherins [J]. J Cell Biol, 2012, 199(2): 365-380.
[10] Maiden SL, Petrova YI, Gumbiner BM. Microtubules inhibit E-cadherin adhesive activity by maintaining phosphorylated p120-catenin in a colon carcinoma cell model [J]. PLoS One, 2016, 11(2): e0148574.
[11] Xia X, Mariner DJ, Reynolds AB. Adhesion-associated and PKC-modulated changes in Serine/Threonine phosphorylation of P120-catenin [J]. Biochemistry, 2003, 42(30): 9195-9204.
[12] Valls G, Codina M, Miller RK, et al. Upon Wnt stimulation, Rac1 activation requires Rac1 and Vav2 binding to p120-catenin [J]. J Cell Sci, 2012, 125(Pt 22): 5288-5301.
[13] Kourtidis A, Ngok SP, Anastasiadis PZ. P120 catenin: an essential regulator of cadherin stability, adhesion-induced signaling, and cancer progression [J]. Prog Mol Biol Transl Sci, 2013, 116: 409-432.
[14] Lai KC, Liu CJ, Chang KW, et al. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells[J]. Oncogene, 2013, 32(32): 3686-3697.